Mr David Lydon > McCann FitzGerald LLP > Dublin, Ireland > Lawyer Profile

McCann FitzGerald LLP is renowned for its comprehensive expertise in the telecoms sector, handling contentious, regulatory, and transactional matters for a diverse client base. The team is well-versed in both contentious and non-contentious issues, with a particular focus on competition aspects of transactions, including acquisitions and joint ventures. The contentious telecoms practice, led by Rosaleen Byrne, Amy Brick, and Catherine Derrig, frequently represents clients in Commercial Court proceedings. On the regulatory and transactional side, David Lydon and Garreth O’Brien provide administrative and corporate law advice to domestic and international clients. Laura Treacy brings significant expertise in telecoms regulation, advising on licensing, interconnection, spectrum allocation, and infrastructure access.

McCann FitzGerald LLP has a prestigious record in corporate and M&A transactions, with the private equity, financial institutions, renewable energy and engineering sectors continuing to drive the practice forward. It remains at the forefront of both public and private M&A; the firm advised WestRock on its headline combination with Smurfit Kappa. David Lydon is a seasoned professional in the market, with head of corporate Stephen FitzSimons, private equity specialist Ben Gaffikin, Garreth O’Brien and financial institutions M&A expert Alan Fuller, also prominent in the market. Brendan Murphy , John Neeson, Gill Lohan  and Stephen Fuller are also key partners. Ciara O’Herlihy was promoted to partner in June 2024. David Byers has retired.

McCann FitzGerald LLP has a broad-based healthcare and life sciences practice covering IP and regulatory issues to product liability, licensing, M&A, spin-offs and strategic alliances. It has a particularly strong reputation in product liability cases, having acted for clients in many of the biggest cases over the last 20 years. It has also landed instructions in most of the large patent disputes in the area and has a solid record in medical malpractice and clinical negligence cases. Roddy Bourke is highly-reputed for product liability cases and mass tort claims. Fiona O’Beirne has vast experience in patent disputes in the medical device, pharmaceutical and bio-pharmaceutical sectors, with Shane O’Brien also prominent in this area. David Lydon has an extensive background in life sciences M&A.